Skip to content

Study the effect of ginger on motion sickness

The comparison of Ginger and Dimenhydrinate in preventing of motion sickness in children at the age of 5-7 years old

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170404033202N7
Enrollment
138
Registered
2018-01-08
Start date
2018-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motion sickness in children ages 5 to 7 years. Vestibular neuronitis

Interventions

Intervention 1: Control group: We ask parents to have a drug that the inquirer gives them half an hour before moving to their children during the day they travel. (Damian hydrating tablets are placed
Treatment - Drugs
Control group: We ask parents to have a drug that the inquirer gives them half an hour before moving to their children during the day they travel. (Damian hydrating tablets are placed in capsules like
Intervention Group: We ask parents to give the child a half hour before moving to the child during a traveler who is ahead of the day. Ginger capsule (zinetoma) is a 250 mg capsule for treating motion

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 7 Years

Inclusion criteria

Inclusion criteria: being at the age of 5-7 years old Having motion sickness absence of physical and psychiatric illness not taking any drugs

Exclusion criteria

Exclusion criteria: Using a lot of fluid before moving. There is less than an hour between the baby's meal and movement Eat greasy food before going to bed Baby is hungry Baby has urine or feces while traveling using the tablet or cellphone while moving Use another medication during treatment Lack of cooperation or intolerance of the child in the use of ginger or vomiting in less than half an hour after taking medication.

Design outcomes

Primary

MeasureTime frame
Nausea. Timepoint: during the trip. Method of measurement: number.;Vomiting. Timepoint: during the trip. Method of measurement: number.;Severe nausea. Timepoint: during the trip. Method of measurement: Visual Scale of Pain.;Sleepiness. Timepoint: during the trip. Method of measurement: Self-declaration - checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Asadi

Sabzevar University of Medical Sciences

aa.9157638703@gmai.com+98 51 4422 9180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026